Europe Proton Therapy Market Size, Share & Industry Trends Analysis Report By Product Type, By Indication (CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others), By End User, By Country and Growth Forecast, 2022 - 2028
The Europe Proton Therapy Market would witness market growth of 12.2% CAGR during the forecast period (2022-2028).
Proton therapy may be chosen by doctors when deciding whether to use photon or proton therapy to treat a tumor if it is crucial to give a higher radiation dose to targeted tissues while dramatically reducing radiation to surrounding organs at risk. In the Model Policy for Proton Beam Treatment of the American Society for Proton therapy, proton radiation therapy is justified when it can benefit the patient while protecting nearby normal tissues and cannot be achieved properly by photon radiation.
Proton radiation therapy is frequently combined with chemotherapy and/or surgery to treat cancer, similar to photon radiation therapy. Isochronous cyclotrons are used in the majority of installed proton treatment systems. Cyclotrons are thought to be reliable, easy to use, and small, especially when superconducting magnets are used. It is also possible to employ synchrotrons, with the benefit of simpler production at various energies. As size and cost restrictions are overcome, linear accelerators—used in photon radiation therapy—are becoming commercially available.
Early identification of breast cancer is frequent in Europe, many women might be qualified for breast-saving surgery (BCT). As cases of breast cancer, lung cancer, liver cancer, and prostate cancer rise, there will be a rising demand for a range of cancer treatments and solutions throughout the region throughout the projection period. This will drive the development and acceptance of the proton therapy market in this area.
The Germany market dominated the Europe Proton Therapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $62,652.5 Thousands by 2028. The UK market would witness a CAGR of 11.3% during (2022 - 2028). Additionally, The France market is anticipated to witness a CAGR of 13.1% during (2022 - 2028).
Based on Product Type, the market is segmented into Accelerator, Beam Delivery System, Beam Transport System, Nozzle & Image Viewers and Patient Positioning System. Based on Indication, the market is segmented into CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others. Based on End User, the market is segmented into Hospitals, Proton Therapy Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product Type
- Accelerator
- Beam Delivery System
- Beam Transport System
- Nozzle & Image Viewers
- Patient Positioning System
- CNS Cancer
- Prostate Cancer
- Head & Neck Cancer
- Breast Cancer
- Others
- Hospitals
- Proton Therapy Centers
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Toshiba Corporation
- Siemens Healthineers AG (Siemens AG)
- Ion Beam Applications SA
- Hitachi, Ltd.
- Mirion Technologies, Inc.
- Mevion Medical Systems, Inc.
- Provision Healthcare
- Sumitomo Corporation
- Optivus Proton Therapy, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Proton Therapy Market, by Product Type
- 1.4.2 Europe Proton Therapy Market, by Indication
- 1.4.3 Europe Proton Therapy Market, by End User
- 1.4.4 Europe Proton Therapy Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenarios
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Strategies Deployed in Proton Therapy Market
- Chapter 4. Europe Proton Therapy Market by Product Type
- 4.1 Europe Accelerator Market by Country
- 4.2 Europe Beam Delivery System Market by Country
- 4.3 Europe Beam Transport System Market by Country
- 4.4 Europe Nozzle & Image Viewers Market by Country
- 4.5 Europe Patient Positioning System Market by Country
- Chapter 5. Europe Proton Therapy Market by Indication
- 5.1 Europe CNS Cancer Market by Country
- 5.2 Europe Prostate Cancer Market by Country
- 5.3 Europe Head & Neck Cancer Market by Country
- 5.4 Europe Breast Cancer Market by Country
- 5.5 Europe Others Market by Country
- Chapter 6. Europe Proton Therapy Market by End User
- 6.1 Europe Hospitals Market by Country
- 6.2 Europe Proton Therapy Centers Market by Country
- 6.3 Europe Others Market by Country
- Chapter 7. Europe Proton Therapy Market by Country
- 7.1 Germany Proton Therapy Market
- 7.1.1 Germany Proton Therapy Market by Product Type
- 7.1.2 Germany Proton Therapy Market by Indication
- 7.1.3 Germany Proton Therapy Market by End User
- 7.2 UK Proton Therapy Market
- 7.2.1 UK Proton Therapy Market by Product Type
- 7.2.2 UK Proton Therapy Market by Indication
- 7.2.3 UK Proton Therapy Market by End User
- 7.3 France Proton Therapy Market
- 7.3.1 France Proton Therapy Market by Product Type
- 7.3.2 France Proton Therapy Market by Indication
- 7.3.3 France Proton Therapy Market by End User
- 7.4 Russia Proton Therapy Market
- 7.4.1 Russia Proton Therapy Market by Product Type
- 7.4.2 Russia Proton Therapy Market by Indication
- 7.4.3 Russia Proton Therapy Market by End User
- 7.5 Spain Proton Therapy Market
- 7.5.1 Spain Proton Therapy Market by Product Type
- 7.5.2 Spain Proton Therapy Market by Indication
- 7.5.3 Spain Proton Therapy Market by End User
- 7.6 Italy Proton Therapy Market
- 7.6.1 Italy Proton Therapy Market by Product Type
- 7.6.2 Italy Proton Therapy Market by Indication
- 7.6.3 Italy Proton Therapy Market by End User
- 7.7 Rest of Europe Proton Therapy Market
- 7.7.1 Rest of Europe Proton Therapy Market by Product Type
- 7.7.2 Rest of Europe Proton Therapy Market by Indication
- 7.7.3 Rest of Europe Proton Therapy Market by End User
- Chapter 8. Company Profiles
- 8.1 Toshiba Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research and Development Expense
- 8.1.5 SWOT Analysis
- 8.2 Siemens Healthineers AG (Siemens AG)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.2.5.2 Acquisitions and Mergers:
- 8.2.6 SWOT Analysis
- 8.3 Ion Beam Applications SA
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Partnerships, Collaborations, and Agreements:
- 8.3.5.2 Product Launches and Product Expansions:
- 8.3.5.3 Acquisition and Mergers:
- 8.4 Hitachi, Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Acquisition and Mergers:
- 8.5 Mirion Technologies, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Product Launches and Product Expansions:
- 8.5.5.2 Acquisition and Mergers:
- 8.6 Mevion Medical Systems, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Partnerships, Collaborations, and Agreements:
- 8.7 Provision Healthcare
- 8.7.1 Company Overview
- 8.8 Sumitomo Corporation
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.9 Optivus Proton Therapy, Inc.
- 8.9.1 Company Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook